BDBM50380623 CHEMBL2016870

SMILES NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4cccc(CC(=O)NCc5cccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)c5)c4)c3)cc1

InChI Key InChIKey=MLVTZWQEWUGCSC-UHFFFAOYSA-N

Data  9 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50380623   

TargetPlasminogen(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  1.10nMpH: 8.0Assay Description:The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/18/2015
Entry Details
US Patent

TargetPlasminogen(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  1.10nMAssay Description:Inhibition of plasmin by dixon plot methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  17.4nMpH: 8.0Assay Description:The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/18/2015
Entry Details
US Patent

TargetPlasma kallikrein(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  17.4nMAssay Description:Inhibition of plasma kallikrein by dixon plot methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetProthrombin(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  26.8nMpH: 8.0Assay Description:The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/18/2015
Entry Details
US Patent

TargetProthrombin(Human)
The Medicines Company (Leipzig)

US Patent
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  26.8nMAssay Description:Inhibition of thrombin by dixon plot methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Philipps University Marburg

Curated by ChEMBL
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  42nMAssay Description:Inhibition of factor 10a by dixon plot methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Philipps University Marburg

Curated by ChEMBL
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  42.1nMpH: 8.0Assay Description:The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/18/2015
Entry Details
US Patent

TargetVitamin K-dependent protein C(Human)
Philipps University Marburg

Curated by ChEMBL
LigandPNGBDBM50380623(CHEMBL2016870)
Affinity DataKi:  223nMAssay Description:Inhibition of activated protein C by dixon plot methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed